ICON PLC

Healthcare · Diagnostics & Research

162.10$ +0.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

ICON PLC (ICLR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,063 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ICLR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	420	435	432	431	440	455	620	642	655	679	675	695	710	725	715	620	702	760	858	871	1,866	1,885	1,902	1,935	1,942	1,962	1,979	2,020	2,055	2,066	2,090	2,120	2,030	2,041	2,001	2,017	2,043	2,190	2,034	2,063	8,330
Cost of Revenue	243	252	250	250	260	267	431	449	459	479	475	491	500	508	505	446	493	535	626	631	1,358	1,357	1,378	1,392	1,376	1,381	1,396	1,430	1,449	1,446	1,471	1,494	1,439	1,442	1,443	1,456	1,587	1,689	1,556	1,675	6,507
Gross Profit	177	184	181	181	181	188	190	192	196	200	199	204	211	217	210	174	208	225	232	240	508	528	523	543	567	581	583	591	606	621	619	627	591	599	559	562	456	501	478	389	1,823
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	76	76	81	81	79	75	81	81	81	77	82	83	78	78	78	84	83	88	99	110	207	203	195	190	167	227	200	188	185	196	177	194	205	151	198	205	197	180	201	194	772
Total Operating Expenses	100	99	96	103	96	98	98	110	98	98	97	98	101	102	104	117	100	105	116	127	503	383	353	365	323	378	366	381	342	355	334	397	306	302	339	352	197	1,959	304	194	2,655
Operating Income	77	85	86	78	85	90	92	82	98	102	102	106	110	115	106	57	108	120	116	113	5.1	145	170	178	244	203	217	209	264	266	285	230	285	297	220	209	259	230	174	194	857
Interest Expense	3.2	3.4	3.2	3.2	3.2	3.1	3.8	3.3	3.2	3.2	3.4	3.2	3.4	3.3	3.2	3.2	3.2	3.4	2.7	25	102	53	44	47	63	75	87	85	84	81	72	61	53	51	48	50	50	40	48	49	187
Pre-Tax Income	74	82	83	75	82	87	89	80	96	100	100	105	109	113	105	54	105	116	113	88	-98	91	125	130	181	128	131	125	182	186	216	170	235	249	174	161	38	-121	128	92	137
Income Tax Expense	10	7.3	12	11	8.2	16	11	7.8	12	12	12	12	13	14	13	6.4	14	15	16	14	-3.6	15	13	14	21	11	14	9.6	18	-30	28	23	37	-11	20	-22	36	–	23	20	–
Net Income	64	74	71	65	74	71	78	72	85	88	88	92	95	99	92	48	92	101	97	74	-94	76	112	116	160	117	117	116	164	216	187	147	197	260	154	183	2.4	-110	105	73	70
EBITDA	96	100	101	93	102	106	109	111	116	117	127	131	135	131	124	73	125	137	141	137	162	299	328	353	400	356	374	368	422	425	437	381	381	366	317	309	187	10	277	294	768

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings